Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C et al (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108–112. https://doi.org/10.1038/nature08460
Article
CAS
PubMed
PubMed Central
Google Scholar
Berens ME, Bjotvedt G, Levesque DC, Rief MD, Shapiro JR, Coons SW (1993) Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma. In Vitro Cell Dev Biol Anim 29a:310–318
Article
CAS
Google Scholar
Bhat KPL, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD et al (2013) Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 24:331–346. https://doi.org/10.1016/j.ccr.2013.08.001 {Bhat H, 2014 #271}
Article
CAS
PubMed
Google Scholar
Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SHet al (2013) The somatic genomic landscape of glioblastoma. Cell 155: 462–477 Doi https://doi.org/10.1016/j.cell.2013.09.034
Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H et al (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318–325. https://doi.org/10.1038/nature08712
Article
CAS
PubMed
Google Scholar
Christensen MV, Hogdall CK, Jochumsen KM, Hogdall EVS (2018) Annexin A2 and cancer: a systematic review. Int J Oncol 52:5–18. https://doi.org/10.3892/ijo.2017.4197
Article
CAS
PubMed
Google Scholar
Eberhard DA, Karns LR, VandenBerg SR, Creutz CE (2001) Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J Cell Sci 114:3155–3166
CAS
PubMed
Google Scholar
Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64:6503–6510. https://doi.org/10.1158/0008-5472.Can-04-0452
Article
CAS
PubMed
Google Scholar
Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev 82:331–371. https://doi.org/10.1152/physrev.00030.2001
Article
CAS
PubMed
Google Scholar
Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699–708. https://doi.org/10.1056/NEJMoa1308573
Article
CAS
PubMed
PubMed Central
Google Scholar
Hampl JA, Camp SM, Mydlarz WK, Hampl M, Ichikawa T, Chiocca EA, Louis DN, Sena-Esteves M, Breakefield XO (2003) Potentiated gene delivery to tumors using herpes simplex virus/Epstein-Barr virus/RV tribrid amplicon vectors. Hum Gene Ther 14:611–626. https://doi.org/10.1089/104303403321618137
Article
CAS
PubMed
Google Scholar
Ichikawa T, Otani Y, Kurozumi K, Date I (2016) Phenotypic transition as a survival strategy of Glioma. Neurol Med Chir 56:387–395. https://doi.org/10.2176/nmc.ra.2016-0077
Article
Google Scholar
Inoue S, Ichikawa T, Kurozumi K, Maruo T, Onishi M, Yoshida K, Fujii K, Kambara H, Chiocca EA, Date I (2012) Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas. World Neurosurg 78:670–682. https://doi.org/10.1016/j.wneu.2011.09.005
Article
PubMed
Google Scholar
Jahani-Asl A, Yin H, Soleimani VD, Haque T, Luchman HA, Chang NC, Sincennes MC, Puram SV, Scott AM, Lorimer IA et al (2016) Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat Neurosci 19:798–806. https://doi.org/10.1038/nn.4295
Article
CAS
PubMed
PubMed Central
Google Scholar
Joseph JV, Conroy S, Pavlov K, Sontakke P, Tomar T, Eggens-Meijer E, Balasubramaniyan V, Wagemakers M, den Dunnen WF, Kruyt FA (2015) Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1alpha-ZEB1 axis. Cancer Lett 359:107–116. https://doi.org/10.1016/j.canlet.2015.01.010
Article
CAS
PubMed
Google Scholar
Kang SH, Yu MO, Park KJ, Chi SG, Park DH, Chung YG (2010) Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblastoma. Neurosurgery 67:1386–1395; discussion 1395. https://doi.org/10.1227/NEU.0b013e3181f1c0cd
Article
PubMed
Google Scholar
Kling T, Ferrarese R, D Oh, Johansson P, Heiland DH, Dai F, Vasilikos I, Weyerbrock A, Jornsten R, Carro MSet al (2016) Integrative modeling reveals Annexin A2-mediated epigenetic control of Mesenchymal Glioblastoma. EBioMedicine 12: 72–85 Doi https://doi.org/10.1016/j.ebiom.2016.08.050
Kucia-Tran JA, Tulkki V, Scarpini CG, Smith S, Wallberg M, Paez-Ribes M, Araujo AM, Botthoff J, Feeney M, Hughes K et al (2018) Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma. J Pathol 244:283–295. https://doi.org/10.1002/path.5010
Article
CAS
PubMed
Google Scholar
Kucia-Tran JA, Tulkki V, Smith S, Scarpini CG, Hughes K, Araujo AM, Yan KY, Botthof J, Perez-Gomez E, Quintanilla M et al (2016) Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival. Br J Cancer 115:212–222. https://doi.org/10.1038/bjc.2016.199
Article
CAS
PubMed
PubMed Central
Google Scholar
Maruo T, Ichikawa T, Kanzaki H, Inoue S, Kurozumi K, Onishi M, Yoshida K, Kambara H, Ouchida M, Shimizu Ket al (2013) Proteomics-based analysis of invasion-related proteins in malignant gliomas. Neuropathology33: 264–275 Doi https://doi.org/10.1111/j.1440-1789.2012.01361.x
Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D (1996) Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271:32635–32643. https://doi.org/10.1074/jbc.271.51.32635
Article
CAS
PubMed
Google Scholar
Onishi M, Ichikawa T, Kurozumi K, Inoue S, Maruo T, Otani Y, Fujii K, Ishida J, Shimazu Y, Yoshida K et al (2015) Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma. Brain Tumor Pathol 32:184–194. https://doi.org/10.1007/s10014-015-0216-6
Article
CAS
PubMed
Google Scholar
Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro-Oncology 19:v1–v88. https://doi.org/10.1093/neuonc/nox158
Article
PubMed
PubMed Central
Google Scholar
Otani Y, Ichikawa T, Kurozumi K, Date I (2019) Dynamic reorganization of microtubule and Glioma invasion. Acta medica Okayama 73:285–297. https://doi.org/10.18926/amo/56930
Article
PubMed
Google Scholar
Otani Y, Ichikawa T, Kurozumi K, Inoue S, Ishida J, Oka T, Shimizu T, Tomita Y, Hattori Y, Uneda A et al (2018) Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion. Oncogene 37:777–786. https://doi.org/10.1038/onc.2017.373
Article
CAS
PubMed
Google Scholar
Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344:1396–1401. https://doi.org/10.1126/science.1254257
Article
CAS
PubMed
PubMed Central
Google Scholar
Puchalski RB, Shah N, Miller J, Dalley R, Nomura SR, Yoon JG, Smith KA, Lankerovich M, Bertagnolli D, Bickley K et al (2018) An anatomic transcriptional atlas of human glioblastoma. Science 360:660–663. https://doi.org/10.1126/science.aaf2666
Article
CAS
PubMed
PubMed Central
Google Scholar
Rainov NG, Koch S, Sena-Esteves M, Berens ME (2000) Characterization of a canine glioma cell line as related to established experimental brain tumor models. J Neuropathol Exp Neurol 59:607–613. https://doi.org/10.1093/jnen/59.7.607
Article
CAS
PubMed
Google Scholar
Repovic P, Fears CY, Gladson CL, Benveniste EN (2003) Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells. Oncogene 22:8117–8124. https://doi.org/10.1038/sj.onc.1206922
Article
CAS
PubMed
Google Scholar
Scherer HJ (1940) A critical review: the pathology of cerebral GLIOMAS. J Neurol Psychiatry 3:147–177. https://doi.org/10.1136/jnnp.3.2.147
Article
CAS
PubMed
PubMed Central
Google Scholar
Shien K, Papadimitrakopoulou VA, Ruder D, Behrens C, Shen L, Kalhor N, Song J, Lee JJ, Wang J, Tang X et al (2017) JAK1/STAT3 activation through a Proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung Cancer. Mol Cancer Ther 16:2234–2245. https://doi.org/10.1158/1535-7163.MCT-17-0148
Article
CAS
PubMed
PubMed Central
Google Scholar
Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845. https://doi.org/10.1038/359843a0
Article
CAS
PubMed
Google Scholar
Smigiel JM, Parameswaran N, Jackson MW (2017) Potent EMT and CSC phenotypes are induced by Oncostatin-M in pancreatic Cancer. Mol Cancer Res 15:478–488. https://doi.org/10.1158/1541-7786.MCR-16-0337
Article
CAS
PubMed
PubMed Central
Google Scholar
Tang Q, Lian Y, Yu J, Wang Y, Shi Z, Chen L (2017) Anatomic mapping of molecular subtypes in diffuse glioma. BMC Neurol 17:183. https://doi.org/10.1186/s12883-017-0961-8
Article
PubMed
PubMed Central
Google Scholar
Tomita Y, Kurozumi K, Yoo JY, Fujii K, Ichikawa T, Matsumoto Y, Uneda A, Hattori Y, Shimizu T, Otani Y et al (2019) Oncolytic herpes virus armed with Vasculostatin in combination with Bevacizumab abrogates Glioma invasion via the CCN1 and AKT signaling pathways. Mol Cancer Ther 18:1418–1429. https://doi.org/10.1158/1535-7163.Mct-18-0799
Article
CAS
PubMed
Google Scholar
Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110. https://doi.org/10.1016/j.ccr.2009.12.020
Article
CAS
PubMed
PubMed Central
Google Scholar
Wakimoto H, Mohapatra G, Kanai R, Curry WT Jr, Yip S, Nitta M, Patel AP, Barnard ZR, Stemmer-Rachamimov AO, Louis DN et al (2012) Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro-Oncology 14:132–144. https://doi.org/10.1093/neuonc/nor195
Article
CAS
PubMed
Google Scholar
Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y et al (2018) Tumor evolution of Glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 33:152. https://doi.org/10.1016/j.ccell.2017.12.012
Article
CAS
PubMed
PubMed Central
Google Scholar
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F et al (2017) Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncol 18:1373–1385. https://doi.org/10.1016/s1470-2045(17)30517-x
Article
CAS
PubMed
Google Scholar
Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, Henriksson R, Le Rhun E, Balana C, Chinot O et al (2017) European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. The Lancet Oncology 18:e315–e329. https://doi.org/10.1016/s1470-2045(17)30194-8
Article
PubMed
Google Scholar
West NR, Murray JI, Watson PH (2014) Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer. Oncogene 33:1485–1494. https://doi.org/10.1038/onc.2013.105
Article
CAS
PubMed
Google Scholar
Womeldorff M, Gillespie D, Jensen RL (2014) Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus 37:E8
Article
Google Scholar
Wu B, Zhang F, Yu M, Zhao P, Ji W, Zhang H, Han J, Niu R (2012) Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells. Cell Prolif 45:189–198. https://doi.org/10.1111/j.1365-2184.2012.00820.x
Article
CAS
PubMed
PubMed Central
Google Scholar
Young N, Pearl DK, Van Brocklyn JR (2009) Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol Cancer Res 7:23–32. https://doi.org/10.1158/1541-7786.Mcr-08-0061
Article
CAS
PubMed
PubMed Central
Google Scholar